Boston Trust Walden’s Pfizer PFE Stock Holding History

Boston Trust Walden’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.61M	Sell	67,014 -1,365	-2%	-$35.7K	0.01%	269
2026 Q1	$1.92M	Sell	68,379 -2,325	-3%	-$61.9K	0.02%	262
2025 Q4	$1.76M	Sell	70,704 -225	-0.3%	-$5.67K	0.01%	257
2025 Q3	$1.81M	Sell	70,929 -33	-0%	-$815	0.01%	256
2025 Q2	$1.72M	Sell	70,962 -1,900	-3%	-$44.3K	0.01%	257
2025 Q1	$1.85M	Buy	72,862 +1,821	+3%	+$47.7K	0.01%	253
2024 Q4	$1.88M	Sell	71,041 -280	-0.4%	-$7.59K	0.01%	255
2024 Q3	$2.06M	Sell	71,321 -1,261	-2%	-$36.8K	0.01%	251
2024 Q2	$2.03M	Sell	72,582 -2,997	-4%	-$82.5K	0.02%	246
2024 Q1	$2.1M	Sell	75,579 -4,820	-6%	-$134K	0.02%	244
2023 Q4	$2.31M	Sell	80,399 -3,751	-4%	-$113K	0.02%	241
2023 Q3	$2.79M	Sell	84,150 -1,847	-2%	-$65.3K	0.02%	235
2023 Q2	$3.15M	Buy	85,997 +1,303	+2%	+$50.7K	0.03%	235
2023 Q1	$3.46M	Sell	84,694 -4,295	-5%	-$186K	0.03%	236
2022 Q4	$4.56M	Hold	88,989	–	–	0.04%	236
2022 Q3	$3.89M	Buy	88,989 +1,445	+2%	+$70.2K	0.04%	235
2022 Q2	$4.59M	Buy	87,544 +1,741	+2%	+$88.7K	0.04%	235
2022 Q1	$4.44M	Sell	85,803 -3,768	-4%	-$196K	0.04%	239
2021 Q4	$5.29M	Buy	89,571 +5,143	+6%	+$255K	0.04%	240
2021 Q3	$3.63M	Sell	84,428 -1,646	-2%	-$72.9K	0.03%	242
2021 Q2	$3.37M	Sell	86,074 -267	-0.3%	-$10.4K	0.03%	249
2021 Q1	$3.13M	Sell	86,341 -275	-0.3%	-$9.76K	0.03%	246
2020 Q4	$3.19M	Sell	86,616 -3,539	-4%	-$130K	0.03%	249
2020 Q3	$3.14M	Sell	90,155 -727	-0.8%	-$25.5K	0.04%	255
2020 Q2	$2.82M	Sell	90,882 -343	-0.4%	-$11.7K	0.04%	256
2020 Q1	$2.83M	Sell	91,225 -5,690	-6%	-$194K	0.05%	247
2019 Q4	$3.6M	Buy	96,915 +95	+0.1%	+$3.38K	0.04%	250
2019 Q3	$3.3M	Sell	96,820 -1,691	-2%	-$61.5K	0.04%	251
2019 Q2	$4.05M	Buy	98,511 +215	+0.2%	+$8.54K	0.05%	245
2019 Q1	$3.96M	Sell	98,296 -3,026	-3%	-$121K	0.05%	244
2018 Q4	$4.2M	Sell	101,322 -748	-0.7%	-$31.1K	0.07%	229
2018 Q3	$4.27M	Buy	102,070 +34	+0%	+$1.31K	0.06%	231
2018 Q2	$3.51M	Sell	102,036 -1,185	-1%	-$40.5K	0.05%	241
2018 Q1	$3.48M	Buy	103,221 +4,364	+4%	+$150K	0.05%	241
2017 Q4	$3.4M	Buy	98,857 +1,538	+2%	+$52.4K	0.05%	243
2017 Q3	$3.3M	Buy	97,319 +95	+0.1%	+$3.05K	0.05%	244
2017 Q2	$3.1M	Buy	97,224 +2,789	+3%	+$88K	0.05%	247
2017 Q1	$3.06M	Buy	94,435 +1,528	+2%	+$48.2K	0.05%	241
2016 Q4	$2.86M	Buy	92,907 +271	+0.3%	+$8.27K	0.05%	243
2016 Q3	$2.98M	Sell	92,636 -572	-0.6%	-$19.1K	0.05%	241
2016 Q2	$3.11M	Buy	93,208 +58	+0.1%	+$1.85K	0.05%	243
2016 Q1	$2.62M	Sell	93,150 -686	-0.7%	-$19.6K	0.05%	249
2015 Q4	$2.87M	Sell	93,836 -3,628	-4%	-$114K	0.05%	241
2015 Q3	$2.9M	Buy	97,464 +3,897	+4%	+$125K	0.05%	249
2015 Q2	$2.98M	Buy	93,567 +538	+0.6%	+$17.5K	0.05%	241
2015 Q1	$3.07M	Buy	93,029 +615	+0.7%	+$19.6K	0.05%	232
2014 Q4	$2.73M	Hold	92,414	–	–	0.04%	232
2014 Q3	$2.59M	Sell	92,414 -176	-0.2%	-$4.94K	0.04%	230
2014 Q2	$2.61M	Hold	92,590	–	–	0.04%	222
2014 Q1	$2.82M	Sell	92,590 -14,394	-13%	-$429K	0.04%	211
2013 Q4	$3.11M	Sell	106,984 -332	-0.3%	-$9.66K	0.05%	212
2013 Q3	$2.92M	Buy	107,316 +12,452	+13%	+$339K	0.04%	210
2013 Q2	$2.52M	Buy	+94,864	New	+$2.62M	0.04%	208

Other funds holding PFE

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

SLAM

Swiss Life Asset Management Zurich $24.1B AUM 38.82% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

CWP

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

Boston Trust Walden's PFE Position: Q2 2026 in Review

Boston Trust Walden reduced its Pfizer (PFE) stake by 2% in Q2 2026, selling an estimated $35.7K and leaving 67,014 shares worth $1.61M. The position accounts for 0.01% of the portfolio, ranked #269.

Boston Trust Walden first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $5.29M in Q4 2021. 1,212 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Boston Trust Walden held 67,014 shares of Pfizer worth $1.61M as of Q2 2026.
Boston Trust Walden sold 1,365 Pfizer shares in Q2 2026, an estimated $35.7K.
Pfizer made up 0.01% of Boston Trust Walden's portfolio in Q2 2026, its #269 holding.
Boston Trust Walden first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
Boston Trust Walden's Pfizer position peaked at $5.29M in Q4 2021.
1,212 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Boston Trust Walden's 13F filing for Q2 2026, filed 24 Jul 2026.